Public companies in the HealthTech sector exhibited median multiples of 1.2 times revenue and 13.5 times EBITDA. We tracked disclosed valuations of HealthTech deals ranging from under 1.5 times revenue to 6.6 times; the representative sales multiples across subsectors were spotted at 6.6 times in the Healthcare IoT subsector, 5.9 times in the Healthcare Ops subsector, 3.6 times in the Telehealth subsector, 1.7 times in the Healthcare IT Services subsector.

Furthermore, 49% of sellers operated under a SaaS business model, and at least 29% engaged in the development of deep technologies such as AI and ML.